Gene mutations have consequences both good and bad—from resistance to conditions like diabetes to susceptibility to certain ...
ZUG, Switzerland and BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRSP), a biopharmaceutical company focused on ...
CASGEVY is a CRISPR/Cas9 gene-edited cell therapy indicated for the treatment of patients aged 12 years and older with (1) ...
University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...
Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
Genes contain instructions for protein production, with the central dogma of biology stating that this information flows from ...